- Home
- PAVS vs XBIO Comparison
PAVS vs XBIO Comparison
Compare PAVS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- XBIO
- Stock Information
- Founded
- PAVS 2004
- XBIO N/A
- Country
- PAVS United States
- XBIO United States
- Employees
- PAVS 11
- XBIO N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- XBIO Health Care
- Exchange
- PAVS Nasdaq
- XBIO Nasdaq
- Market Cap
- PAVS 46.7M
- XBIO 5.7M
- IPO Year
- PAVS 2019
- XBIO N/A
- Fundamental
- Price
- PAVS $0.70
- XBIO $3.68
- Analyst Decision
- PAVS
- XBIO Hold
- Analyst Count
- PAVS 0
- XBIO 1
- Target Price
- PAVS N/A
- XBIO N/A
- AVG Volume (30 Days)
- PAVS 456.2K
- XBIO 19.9K
- Earning Date
- PAVS 10-25-2024
- XBIO 11-08-2024
- Dividend Yield
- PAVS N/A
- XBIO N/A
- EPS Growth
- PAVS N/A
- XBIO N/A
- EPS
- PAVS N/A
- XBIO N/A
- Revenue
- PAVS $6,544,819.00
- XBIO $2,520,358.00
- Revenue This Year
- PAVS N/A
- XBIO N/A
- Revenue Next Year
- PAVS N/A
- XBIO N/A
- P/E Ratio
- PAVS N/A
- XBIO N/A
- Revenue Growth
- PAVS N/A
- XBIO 16.79
- 52 Week Low
- PAVS $0.32
- XBIO $2.78
- 52 Week High
- PAVS $3.10
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- PAVS 44.35
- XBIO 42.23
- Support Level
- PAVS $0.67
- XBIO $3.56
- Resistance Level
- PAVS $0.75
- XBIO $3.82
- Average True Range (ATR)
- PAVS 0.14
- XBIO 0.38
- MACD
- PAVS -0.00
- XBIO -0.07
- Stochastic Oscillator
- PAVS 56.23
- XBIO 7.84
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.